-
1
المؤلفون: Marina Nechaeva, Assen Dudov, Martin Schuler, Salah-Eddin Al-Batran, Zanete Zvirbule, Ugur Sahin, Christoph Huber, Yuriy Vynnyk, Andriy Rusyn, Natalia Fadeeva, Florian Lordick, Igor Bondarenko, Igor Bazin, Ihor Vynnychenko, Georgiy Manikhas, Christian Mueller, Alexander Pecheniy, Ö. Türeci, Evgeny Gotovkin, Bohuslav Melichar
المصدر: Journal of Clinical Oncology. 34:LBA4001-LBA4001
مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, biology, business.industry, Cancer, medicine.disease, Oxaliplatin, Capecitabine, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Trastuzumab, 030220 oncology & carcinogenesis, Internal medicine, Cancer cell, biology.protein, Medicine, Adenocarcinoma, Antibody, business, medicine.drug, Epirubicin
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e2f9f7babf7a4da78ea88a25a470619
https://doi.org/10.1200/jco.2016.34.18_suppl.lba4001